Press-release for stocks in the manufacturing sector related to biotech

Prices are updated after-hours

sector : Manufacturing tags : Biotech

save search

Black Bird Biotech Announces New CEO; Provides Commentary on Refreshed Path
Published: 2024-04-16 (Crawled : 12:00) - globenewswire.com
BBBT | $0.0001 0.0% 22M

Manufacturing

| 50.0% | O: 100.0% H: 0.0% C: -25.0%
biotech

Avalo Therapeutics Appoints Biotech Leaders to Board of Directors
Published: 2024-04-02 (Crawled : 12:00) - globenewswire.com
AVTX | $11.71 -2.5% -2.56% 68K

Manufacturing

| -40.14% | O: -22.8% H: 15.52% C: 1.07%
ICLR | $288.32 -1.2% -1.21% 640K

Health Technology

| -14.55% | O: -2.95% H: 0.0% C: -1.43%
BIIB | $194.39 2.03% 1.99% 1.6M

Health Technology

| -9.79% | O: -1.11% H: 0.16% C: -2.56%
biotech leaders therapeutics

Purple Biotech to Present New Data On its Oncology Drug NT219 at AACR 2024
Published: 2024-03-28 (Crawled : 11:00) - globenewswire.com
PPBT | $0.456 -1.09% -1.1% 52K

Manufacturing

| -25.81% | O: 0.0% H: 8.06% C: 8.06%
nt219 drug biotech purple

Purple Biotech Reports Preclinical Proof of Concept for its Tribody Platform Technology
Published: 2024-03-14 (Crawled : 12:00) - globenewswire.com
PPBT | $0.456 -1.09% -1.1% 52K

Manufacturing

| -35.31% | O: 4.06% H: 0.0% C: -6.04%
biotech preclinical purple technology platform

Purple Biotech Reports Fourth Quarter and Full-Year 2023 Financial Results
Published: 2024-03-05 (Crawled : 13:00) - globenewswire.com
PPBT | $0.456 -1.09% -1.1% 52K

Manufacturing

| -44.58% | O: -4.58% H: 4.8% C: 1.01%
biotech purple financial results

Purple Biotech Presents Data of its Phase 1 Head & Neck Cancer of NT219 in combination with Cetuximab at ESMO TAT Congress 2024
Published: 2024-02-27 (Crawled : 12:00) - globenewswire.com
PPBT | $0.456 -1.09% -1.1% 52K

Manufacturing

| -35.46% | O: 2.99% H: 0.0% C: -8.64%
nt219 biotech congress cancer purple

Purple Biotech Convenes a Head & Neck Cancer Scientific Advisory Board in Preparation for NT219 Phase 2 Trial
Published: 2024-02-13 (Crawled : 12:00) - globenewswire.com
PPBT | $0.456 -1.09% -1.1% 52K

Manufacturing

| -38.67% | O: 4.01% H: 7.74% C: -3.82%
nt219 biotech cancer purple trial

Evaxion Biotech Announces Pricing of $15 Million Public Offering
Published: 2024-02-01 (Crawled : 14:00) - globenewswire.com
EVAX | $4.2 -0.47% -0.48% 31K

Manufacturing

| 9.67% | O: 2.04% H: 31.92% C: 14.71%
biotech million offering

Purple Biotech Reaches Recommended Phase 2 Dose for NT219
Published: 2024-02-01 (Crawled : 12:30) - globenewswire.com
PPBT | $0.456 -1.09% -1.1% 52K

Manufacturing

| -30.3% | O: 3.03% H: 9.01% C: 1.54%
nt219 biotech purple

NightHawk’s Scorpius BioManufacturing Subsidiary Awarded Multimillion- Dollar Contract with a Publicly Traded Biotech Company to Support its Phase 2 Clinical Program
Published: 2024-01-25 (Crawled : 13:30) - globenewswire.com
NHWK | $0.4135 0.0% 170K

Manufacturing

| Email alert Add to watchlist
company biotech contract program

Phoenix Biotech Files Proxy on CERo Therapeutics Deal
Published: 2024-01-23 (Crawled : 15:30) - spacfeed.com
PRSO | $1.365 -7.77% -8.42% 190K

Manufacturing

| -79.36% | O: -3.64% H: 4.79% C: 0.16%
PB A | $60.77 1.81% 0.0% 630K

Finance

| -9.19% | O: 0.13% H: 0.34% C: -2.31%
biotech deal therapeutics

Evaxion Biotech Announces Closing of Private Placement
Published: 2023-12-21 (Crawled : 22:00) - globenewswire.com
EVAX | $4.2 -0.47% -0.48% 31K

Manufacturing

| -37.43% | O: -0.32% H: 3.41% C: 3.41%
biotech

Purple Biotech Appoints Dr. Yael Margolin to its Board of Directors
Published: 2023-12-20 (Crawled : 13:00) - globenewswire.com
PPBT | $0.456 -1.09% -1.1% 52K

Manufacturing

| -53.06% | O: -5.11% H: 3.97% C: -4.28%
PNT | $13.68 2.63% 0.15% 0

| 0.36% | O: 0.12% H: 0.0% C: 0.0%
biotech purple

Evaxion Biotech Announces Private Placement Financing
Published: 2023-12-19 (Crawled : 14:30) - globenewswire.com
EVAX | $4.2 -0.47% -0.48% 31K

Manufacturing

| -32.76% | O: 7.64% H: 1.45% C: -9.86%
biotech

Purple Biotech Completes Patient Enrollment in Phase 2 Pancreatic Cancer Trial
Published: 2023-12-14 (Crawled : 12:00) - globenewswire.com
PPBT | $0.456 -1.09% -1.1% 52K

Manufacturing

| -47.37% | O: 4.12% H: 2.64% C: -3.3%
biotech cancer pancreatic purple trial

Purple Biotech Reports Third Quarter 2023 Financial Results
Published: 2023-11-21 (Crawled : 12:00) - globenewswire.com
PPBT | $0.456 -1.09% -1.1% 52K

Manufacturing